Wadhane Jitendra bought PYXS
March 24, 2026 · Form 4 insider transaction
Wadhane Jitendra bought 109,461 shares of Pyxis Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
109,461
Price
$0.00
Total value
N/A
InsiderWadhane Jitendra
RoleOfficer
CompanyPyxis Oncology, Inc. (PYXS)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 24, 2026
Filing dateMarch 25, 2026
Shares owned after512,882
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units that vest 25% on March 31, 2026, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.